JSAM
EW icon

J. Safra Asset Management’s Edwards Lifesciences EW Stock Holding History

J. Safra Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Sell
206
-256
-55% -$21.4K ﹤0.01% 333
2026
Q1 		$37K Buy
462
+266
+136% +$21.9K ﹤0.01% 274
2025
Q4 		$16.7K Buy
196
+186
+1,860% +$15.3K ﹤0.01% 328
2025
Q3 		$778 Buy
+10
New +$781 ﹤0.01% 456
2022
Q3 		– Hold
0
– – – 72
2022
Q1 		– Hold
0
– – – 139

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

J. Safra Asset Management's EW Position: Q2 2026 in Review

J. Safra Asset Management reduced its Edwards Lifesciences (EW) stake by 55% in Q2 2026, selling an estimated $21.4K and leaving 206 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

J. Safra Asset Management first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $37K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • J. Safra Asset Management held 206 shares of Edwards Lifesciences worth $18.6K as of Q2 2026.
  • J. Safra Asset Management sold 256 Edwards Lifesciences shares in Q2 2026, an estimated $21.4K.
  • Edwards Lifesciences made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #333 holding.
  • J. Safra Asset Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • J. Safra Asset Management's Edwards Lifesciences position peaked at $37K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.